First step: testing a Drug's safety in people with liver issues
NCT ID NCT06841315
Summary
This early-stage study aimed to understand how a single dose of an experimental drug, varegacestat, is processed by the body in people with different levels of liver impairment compared to healthy people. It involved 35 adults, some with liver problems and some without, to measure drug levels and check for side effects. The goal was to gather basic safety and dosing information for future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Orlando Clinical Research Center
Orlando, Florida, 32809, United States
-
The Texas Liver Institute
San Antonio, Texas, 78215, United States
Conditions
Explore the condition pages connected to this study.